Revolution Medicines Email Format

Biotechnology ResearchCalifornia, United States1001-5000 Employees

Revolution Medicines is a biotechnology research company based in Redwood City, California, focused on discovering, developing and delivering targeted medicines for cancer patients. The company concentrates on cancers driven by RAS pathways, with a focus on RAS-addicted cancers that account for about 30 percent of new cancer diagnoses. It employs roughly between 1,001 and 5,000 people and is advancing targeted therapies including daraxonrasib and zoldonrasib, with the FDA authorizing a May 2026 Expanded Access Program for daraxonrasib. In 2026 it is described as a late-stage clinical oncology company developing targeted therapies for patients with RAS-addicted cancers, and it presented updated Phase 1 data for zoldonrasib at the AACR Annual Meeting. The company maintains a corporate website at revmed.com.

Sign up for free to view info

Company overview Employee directory